close

Вход

Забыли?

вход по аккаунту

?

Патент USA US3045042

код для вставки
‘rates
3,945,032 I ,
Patented July 17, 119,62 ‘ '
l.
Robinson, Serial No. 7,107, ?led February 8, 1960. .- Ac
cording to this process, androsterone is converted ‘to the
intermediary 16-hydroxymethylene (l6-formyl) or 16
ethoxalyl androsterone by methods well known in the art;
3,045,032
FLUQRHNATED ANDRBSTANEg
Cecil H. Robinson, Qedar Grove, and Eugene P. Oliveto,
Glen Ridge, N..l'., assignors to Schering Corporation,
, We prefer to formylate'the activated C-16 position by
reacting androsterone with ethyl formate and sodium ‘
methoxide or sodium hydride utilizing as solvent, benzene
or tetrahydrofuran or mixtures thereof. The l6-formyl
Bloom?eld, N.J., a corporation of New Jersey
No Drawing. Filed Feb. 8, 1960, Ser. No. 7,116
6 Claims. '(Cl. 26tl--397.4)
This invention relates to novel, therapeutically active
derivative thereby obtained apparently exists in two tau
steroids of the androstane series. More speci?cally, this 10 tomeric forms, namely formyl and hydroxymethylene.
invention relates to 16,16-di?uoroandrostanes which are
saturated in the A-ring and have an-oxygen function at
0-17. In particular, our invention encompasses 16,16
di?uoro derivatives of androsterones and of androstane
diol-3a,l7B as well as the l6,16—di?uoro-l7u-alkyl and 15
l6,l6-di?uoro-l7a-alkynyl derivatives of the aforemen
tioned androstanediol, including intermediates in the prep
Alternatively, the l6-ethoxalyl derivative of androsterone
is prepared according to procedures similar to those for
preparing the 16-hydroxymethylene derivatives. by using
ethyl oxalate as reagent instead of ethyl formate.
By reacting the intermediary l6-hydroxymethylene
androsterone or l6-ethoxalylandrosteronewith perchloryl
?uoride in the presence of alkoxide preferably potassium
t-butoxide in t-butanol solvent, there is obtained 16,16
aration thereof. -
Our novel l6,léédi?uoroandrostaneshave the following ‘
di?uoroandrosterone, a novel compound of our inven- '
general formula:
tion.
Y
ona
z
i
.
>
The compound 16,16-di?uoroandrosterone, prepared as
described above, may be transformed to the 17a-1ower
alkynyl-l7?-hydroxy or 17u-lOW6I' alkyl-l7/3-hydroxy an
on,
F
alogs by known methods.
25
For example, 16,16-di?uoro- I
androsterone is readily transformed to l6,l6~di?uoro—
l7a-methylandrostane-3a,17?-diol by the well’ known
Grignard reaction utilizing methyl magnesium iodide, .or
to the corresponding l7ot-ethinyl derivative by means of
sodium or potassium acetylide. The l7~hyclroxy com
30 pound,_i.e. l6,16=di?uoroandrostane-3a,17,8-diol is con~
veniently obtained from the l7-keto analog by reduction
wherein Z is a member of the group consisting of O,
30-
I
V
with lithium aluminum hydride, sodium borohydride, plat
(H, 50R’), (Ct-IOWBI' alkyl, 30R’) and (oc-10W61‘ alkynyl,
inum and hydrogen, and the like.
?OR’) wherein R andR’ are members of the group con
By substituting suitable reagents in the aforementioned
sisting of H and an acyl radical of a hydrocarbon car 35
reactions, such as ethyl magnesium bromide instead of’
boxylic acid containing up to eight carbon atoms. R and
R’ may be alike or different.
methyl magnesium iodide in the Grignard reaction on
16,16-di?uoroandrosterone, there are obtained higher
alkyl homologs at C-17 for example, 16,16-di?uoro-‘17a
,
Our invention therefore includes novel compounds such
as 16,16-di?u0roandrostane-3m-ol-l7-one (16,16-diiluoro
androsterone) , 16,16-di?uoroandrostane-3a,17,6-diol ( 16,— 40
16 - di?uoroandrostanediol - 30;,175), l6,16_- di?uoro
17cc - methylandrostane - 304,176 - diol, 16,1-6 - di?uoro
17a-ethinylandrostane-3u,17,8-diol, and the lower alka
noate esters thereof.
By lower alkyl is contemplated hydrocarbon radicals
having up .to four carbon atoms and includes methyl,
ethyl, n-propyl, isopropyl, n-butyl and the like.
By lower alkynyl is contemplated hydrocarbon radicals
ethylandrosterone-l7,8-01. In preparing higher C~l7
homologs of 16,l6-di?uoro-17a~ethinylandrosterone-17p
‘ ‘
01, it is preferred to alkylate the active hydrogen on the
ethinyl moiety by means of lithium and methyl iodide, for
example, to obtain 1‘6,l6-di?uoro-17a-(1’-propynyl)-an
drostane-3a,l7/S-diol. When ethyl iodide and lithium are
45 reacted with the aforementioned l7a-ethinyl derivatives 2
there is ‘obtained the corresponding l7ot-butynyl com
pound, , i.e.
16,16-d1'?uor0-17a-(l'-butynyl)-androstane~
having up to four carbon atoms possessing a triple-bond
Alternatively, our 16,16-di?uoroandrostanes maybe
stemming from the carbon attached to the l7-carbon of 50
prepared from l6,l6~di?uoro-5-androstenes. For exam
the steroid nucleus. Included in this groupv are radicals
ple, l6,l6-di?uoro~5-androstene-3B-ol-l7-one prepared as
such as ethinyl, l-propynyl and l-butynyl.
described in copending application, Serial No. 7,107, ?led
The acyl radicals of hydrocarbon carboxylic acids con
February 8, 1960, from l6-hydroxy-methylene-S-andros
taining up to eight carbon atoms are preferably radicals of
tone-3 ?-ol- l 7-one and perchloryl ?uoride upon hydrogena-,
lower alkanoic acids such as acetic, propionic, valer-ic, 55 tion
in ethyl acetate utilizing'platinum oxide as catalyst
butyric, caproic acid and the like.
,
yields
l6,l6-di?uoroandrostane-3B-ol-17-one. ‘Conversion
The novel 16,16-di?uoroandrostanes of the general
of, the 3/8-hydroXyl group to the 3-keto is effected by a
formula are therapeutically valuable in that they cause
, chromic acid oxidation to give 16,16-di?uoroandrostane
a reduction in serum cholesterol. This property renders
our novel compounds valuable in the treatment and 60 3,17-dione. Alternatively, esteri?cation of ‘the iii-hydrox
yl group with p-toluenesulfonic acid in pyridine, for’ eX
prevention of diseases which are accompanied by an in
crease in serum cholesterol, particularly, for example,
in the treatment of atherosclerosis.
The preferred species of the therapeutically active 16,
by
ample, gives 16,16-di?uoroandrostane-3,8-ol-l7-one~3étos-,
ylate. Displacement of the 3B-tosylate by sodium acetate ‘
using known techniques to give thecorresponding 3a-ace
I toxy-16,l6-di?uoroandrostane-17-one followed by hy
16-di?uoroandrostanes of the general formula as described 65
drolysis with ethanolic potassium hydroxide yields 16,16- ' ‘
herein above is 16,16-di?uoroandrostane-3a-ol-l7-one,
di?uoroandrostane-Stat-01717-one
of our invention. In like
which is useful as an intermediate for preparing the other
manner, utilizing similar techniques other 16,16-di?uoro_—
16,16-di?uoro compounds of this invention as well as
S-androstenes described in copending application, Serial
being therapeutically active per se.
No.
7,107, ?led February 8, 1960, such as 16,16-di?uor'o
Our novelrcompounds are conveniently prepared from 70 _l7a-methyl-5-androstene-3/8,17,8-diol
are convertible to the‘
androsterone (androstane-3a-ol-17-one) by utilizing the
novel process ‘described in the copending application of
corresponding 16,16-di?uoroandrostanes of this invention, >
a in
‘
3,045,032
4
3
EXAMPLE 3
The 3a-hydroxy-16,16-di?uoroandrostanes of the gen
eral formula possessing an ester group at 17, are conven
iently prepared by known techniques from the correspond
ing 17-hydroxy~l6,16-difluoroandrostane by selective es
To a stirred solution of methyl magnesium iodide (pre
teri?cation at C-17 with pyridine and a lower alkanoyl lit pared from 3 g. of magnesium and 7.5 ml. of methyl
iodide) in 250 ml. of anhydrous ether is added drop
anhydride. For example, 16,16-di?uoroandrostane-3a,
wise
with stirring one gram of 16,16-di?uoroandrostane
17B-diol reacted with approximately a molar equivalent
of acetic anhydride in pyridine yields the 17-monoacetate,
i.e. 16,l6-di?uoroandrostane-3a,17/3-diol 17-acetate. By
substituting other lower alkanoyl anhydrides such as pro
pionyl anhydride or caproic anhydride, the corresponding
17-lower alkanoate is obtained, i.e. the 17-propionate and
17-caproate respectively of l6,16-di?uoroandrostane-3u,
17/i-diol.
When preparing 3,17-diesters of the general formula, the
corresponding 3,17-diol is preferably reacted in pyridine
with at least two moles of acid anhydride per mole of
steroid. Usually an‘ excess of acid anhydride is used, and
it is often desirable to apply heat to hasten the esteri?ca
tion process.
The following examples are shown by way of illustra
tion only and are not to be construed as limiting the
scope of our invention, the scope of our invention being
3e-ol-17-one (the compound of Example 1) in 50 ml. of
tetrahydrofuran. 150 ml. more of tetrahydrofuran is
added and the mixture is distilled until 250 ml. of distillate
is collected. The reaction mixture is re?uxed for one hour
longer, then cooled and diluted with ice-cold 10% aqueous
aluminum sulfate solution. A solid separates which is
?ltered, washed with water, dried and chromatographed
on Florisil.
Hexane-ether (1:1) eluates are combined
and evaporated in vacuo to give 16,16'di?llOr0-17u-I1'16th
ylandrostane-3a,17;9-diol.
In a similar manner, by substituting other alkyl Grig
nard reagents such as ethyl magnesium iodide and n-pro
pyl magnesium bromide for methyl magnesium iodide in
the above procedure, there is obtained 16,16-di?uoro-17a
ethylandrOstane-Ba,17,8-diol and 16,16-di?uoro-17a-n-pro
pylaridrostane-3a,17,6-dio1, respectively.
de?ned by the appended claims.
EXAMPLE 4
EXAMPLE 1
16,16-Di?u0r0androstane-3u,17,8-Di0l
1 6,1 6-Di?uoroandrostane-3 a-Ol-I 7-0ne
500 mg. of 16,16-di?uoroandrostane-3a-ol-17-one (the
compound of Example 1) is dissolved in 50 ml. of iso
propanol to which is added 900 mg. of sodium borohy
A. 16-hydr0xymethyIeneandr0stane-3a-0l-17-0ne.—To
a solution of one gram of androsterone in 20 ml. of tetra
dride. The solution is heated on the steam bath for one
hydrofuran is added one gram of sodium methoxide.
While the reaction is stirred under an atmosphere of nitro
gen, 8 ml. of ethyl formate is added dropwise over a 30
hour, then cooled and diluted With 150 ml. of water. A
minute period. The reaction mixture is then stirred under
nitrogen 18 hours at room temperature. Ice and water
(150 ml.) is added to give a yellow solution which is
stirred and neutralized by the dropwise addition of con
cented hydrochloric acid. A solid precipitates which is
?ltered, washed with water’ and dried in vacuo to give
16-di?uoroandrostane-3u,17,8-diol.
1?-hydroxymethyleneandrostane-3a-ol-17-one,
AL??? 265 mp (e 9,100)
B. 16,16-di?uor0androstane-3a-0l-17-0ne.--To a solu
tion of one gram of 16-hydroxymethyleneandrostane-3ot
ol-17-one in 150 ml. of t-butanol is added 20 ml. of a one
molar solution of potassium in t-butanol.
Perchloryl
solid precipitates which is ?ltered, washed with water,
dried and crystallized from aqueous methanol to give 16.
EXAMPLE 5
1 6,1 6 -Di?uoraandrostan 2-3 a,1 7f3-Di0l 1 7-Acetate
To
3.28 g. of 16,16-di?uoroandrostane-3a-17?-diol (the
40
compound of Example 4) in 24 ml. of pyridine is added
1.03 ml. of acetic anhydride. The solution is left at room
temperature for eight hours, then diluted with water. A
solid separates which is ?ltered, washed with Water and
dried to give 16,16-di?uoroandrostane-3a,17;3-diol 17-ace
tate.
By substituting other lower alkanoic acid anhydrides
such as propionic or caproic for acetic anhydride in the
?uoride gas is bubbled through the solution at room tem
above procedure there is obtained the corresponding 17
perature for 90 minutes. The reaction mixture is then di
propionate or 17-caproate respectively of 16,16-di?uoro
luted with 500 ml. of water and extracted with methylene
androstane-3a,17/3-diol.
chloride. The extracts are combined, washed with water
and evaporated to a residue which is chromatographed on
EXAMPLE 6
Florisil. The hexane-ether (1:1) eluates are combined
Alternate Method 0]‘ Preparing 16,16-Di?uor0androstane
and evaporated in vacuo to give a residue which is crystal
3124-01-1 7-One
lized from hexane-ether to give 16,16-di?uoroandrostane- CA, CI!
A. 16-ethoxalylandrostaneda-ol-Z7-one.--To a stirred
3e-ol—l7-one, M.P. l33-l36° G, [0:11) +102".
solution of 10 g. of sodium methoxide in 60 ml. of ethyl
EXAMPLE 2
oxalate and 60 ml. of benzene under an atmosphere of
nitrogen there is ‘added dropwise a solution containing
60 10 g. of androstane-3u-ol~17-one in 5 m1. of benzene and
A. 6.5 ml. portion of a 17% suspension of sodium
acetylide in xylene is centrifuged and the supernatant
liquid removed and replaced by 15 ml. of dimethylsulfox
ide. The resultant suspension is added to a stirred solu
tion of one gram of 16,16-di?uoroandrostane-3a-ol-17-one
in 100 ml. of dirnethylsulfoxide at room temperature. The
reaction mixture is stirred at room temperature for 30
minutes, then water and ice are added. A solid separates
100 m1. of tetrahydrofuran. The reaction mixture is
stirred under nitrogen at room temperature for 18 hours.
The mixture is then ?ltered, poured into 350 ml. of water
with stirring and neutralized with 6 N hydrochloric acid.
' A solid separates which is ?ltered, washed with water and
dried to give 16-ethoxalylandrostane~3a-ol-17-one which
is used without further puri?cation in the following pro
cedure.
which is ?ltered, washed with water, dried and crystal
B. 16,16-di?uoroandrostane-é’u-ol-l7-one.-—16-ethoxal
lized from acetone-hexane to give 16,16-di?uoro-17u 70 ylandrostane-3u-ol-17-one
is reacted with perchloryl ?uo
cthinylandrostane-l3a-17B-diol.
’
ride in t-butanol in the presence of potassium t-butoxide
In a similar manner, by substituting sodium methyl
in the manner described in Example 113. The resultant
acetylidefor sodium acetylide in the above procedure,
product is isolated and puri?ed as described to give 16,
there is obtained 16,16¢ditluoro-17a-(1-propynyl)-andros
tane-3a-l7B-diol.
75 16-di?uoroandrostauc-3a-ol-l7-one.
5
3,045,032
6
EXAMPLE 7
1 6,16-Di?uoroandr0stane-3a-Ol-17-One 3-A cetate
To 3.28 g. of 16,16-diiluoroandrostane-3et-ol-17-one
We claim:
1. A compound having the following general formula:
0H,
(the compound of Example 1) in 24 ml. of pyridine is 5
added 1.03 ml. of acetic anhydride. The solution is
2
CH3
I
.
F
heated on a steam bath for one hour then diluted with
water. A solid separates which is ?ltered, washed with
water, dried and recrystallized from acetone-hexane to
give 16,16-di?uoroandrostane-3a-ol-17-one 3-acetate.
F
10
In a similar manner, by substituting other lower alka
noic acid 'anhydrides such as propionic or valeric for
acetic anhydride in the above procedure there is obtained
the corresponding 3-propionate and 3-valerate, respec
tively of 16,16-di?uoroandrostane-3 oc-Ol-17-0116.
wherein Z is a member of the group consisting of O,
15
H
EXAMPLE 8
1
I
iloweralkyl
OR’
l6,16-Di?uoroandr0stane-3a,17?-Di0l Diacetate
lloweralkynyl
and
I
\OR’
wherein R and R’ are members of the group consisting
To 3.28 g. of 16,16-Cli?ll01‘03l1dI‘OSt3Il6-3oc,l7l3~di0l (the
compound of Example 4) in 50 ml. of pyridine is added 20 of H and an acyl radical of a hydrocarbon carboxylic
acid containing up to eight carbon atoms.
2.5 ml. of acetic anhydride. The solution is heated on
the steam bath for one hour .then diluted with water.
l6-di?uoroandrostane-3a,17,8-diol diacetate.
In a similar manner, by substituting other lower alka
noic acid anhydrides such as propionic or Valerie for
acetic anhydride in the above procedure there is obtained
the corresponding 3,17-dipropionate and 3,17-divalerate
respectively of 16,16-di?uoroandrostane-3u,17p-diol.
gmutson
. 16,16-di?uoroandrostane-3u-ol-17-one.
A solid separates which is ?ltered, Washed with Water,
dried and recrystallized ‘from acetone-hexane to give 16,
. 16,16-di?uoroandrostane-3a,17p-diol.
. 16,16-di?uoro-l7a-methylandrostane-3u,17/3-di0l.
25
. '16,16-di?uoro-17u-ethinylandrostane-3a,17?-diol.
16,l6-di?noroandrostane-3u-ol-17-one 3-acetate.
References Cited in the ?le of this patent
Pappo et al.l' “Journal of the American Chemical So
ciety,” vol. 78 (1956). Pages 6347-6353 relied on.
Документ
Категория
Без категории
Просмотров
0
Размер файла
435 Кб
Теги
1/--страниц
Пожаловаться на содержимое документа